
Member of the European Parliament · Belgium Renew
Olivier Chastel
MEP for Belgium · Renew Europe · Mouvement Réformateur · official EP profile
As of 12 September 2026, Olivier Chastel (Renew, Belgium) has declared 58 lobby meetings this term - rank 353 of 719 MEPs by declared meetings.
That is somewhat below the Parliament average of 85 meetings per MEP, and 60 of 77 within Renew Europe.
61% of this MEP's declared counterpart entries, including diplomatic and government entries, carry a declared EU Transparency Register link - above the like-for-like raw Parliament-wide share of 51%.
Compare with the rest: search and sort all 719 MEPs, or see every MEP from Belgium.
Compared with the averages
Transparency this term
Monthly declared meetings (bars) and the share of all counterpart entries carrying a declared Register link, including diplomatic and government entries (line), July 2024 to September 2026. This is the same current-term window as the figures above, beginning 16 July 2024.
Current month, partial through 11 Sep 2026: 1 declared meeting in Sep 2026, 0% of all counterpart entries carry a declared Register link. Peak: 11 in Mar 2025.
Busiest month: 11 declared in March 2025. Months with no declared meetings have no Register-share value.
Who Olivier Chastel meets most
| Declared counterpart | Meetings |
|---|---|
| Nuclear Medicine Europe | 2 |
| Fédération belge des industries chimiques et des sciences de la vie | 2 |
| APCO Worldwide | 2 |
| Novartis International AG | 2 |
| Ending Discrimination Against Cancer Survivors | 1 |
Counterparts are merged by resolved Transparency Register identity where possible. An entry counts as register-linked above only when the MEP declaration itself carries a Register link.
Where the meetings cluster
Most-met sectors
Health & pharma (28), Public affairs & consultancy (7), Chemicals & manufacturing (1)
Meetings by committee topic
Public Health (37), Environment, Climate and Food Safety (7), Budgets (1), Budgetary Control (1), Women's Rights and Gender Equality (1)
Most recent declared meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 7 Sep 2026 | GAIA | Member | animal welfare |
| 15 Jul 2026 | ZOETIS | Member | Politique de santé de l'UE- Biotech Act |
| 3 Jul 2026 | UCB ↗ | Member | Politique de Santé de l'UE - Biotech Act |
| 11 Jun 2026 | The European Association of Medical Devices – Notified Bodies ↗ | Member | MDR |
| 24 Apr 2026 | Nuclear Medicine Europe | Member | Politique de santé de l'UE |
| 15 Apr 2026 | European Association of Biomedical Scientists | Shadow rapporteur | Politique de santé de l'UE |
| 9 Apr 2026 | European Kidney Health Alliance ↗ | Member | Politique de santé de l'UE |
| 7 Apr 2026 | e-Origin | Shadow rapporteur for opinion | EU customs |
| 27 Mar 2026 | Fourtold ↗; Coalition for Epidemic Preparedness Innovations ↗ | Shadow rapporteur | Politique de santé de l'UE |
| 26 Mar 2026 | GARDP Foundation ↗; APCO Worldwide ↗ | Shadow rapporteur | Politique de santé de l'UE |
Show 20 more meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 18 Mar 2026 | Novartis International AG ↗ | Member | Politique de santé de l'UE: Thérapies par Radioligands |
| 27 Feb 2026 | Alpha-1 Europe Alliance asbl | Member | Alpha-1 awareness raising event |
| 12 Feb 2026 | Andros | Member | Politique de santé de l'UE |
| 5 Feb 2026 | Prospero & Partners ↗ | Member | Omnibus Food and Feed |
| 29 Jan 2026 | HIPRA, S.A. ↗ | Member | Politique de santé de l'UE |
| 28 Jan 2026 | European Association of E-Pharmacies ↗ | Member | Politique de santé de l'UE |
| 15 Jan 2026 | Alpha-1 Europe | Member | Politique de santé de l'UE |
| 11 Dec 2025 | D&D Consulting Services ↗ | Member | Politique environnementale de l'UE |
| 11 Dec 2025 | Essenscia | Member | Politique de santé de l'UE |
| 20 Nov 2025 | RPP Group Alpha-1 foundation | Member | Evènement - Politique de santé de l'UE - Maladie rare Alpha-1 |
| 17 Oct 2025 | Belgaqua EurEau | Member | Politique environnementale de l'UE - Résilience du secteur de l'eau |
| 30 Sep 2025 | Nuclear Medicine Europe ↗ | Member | Politique de santé de l'UE - Médecine nucléaire |
| 24 Sep 2025 | FIPRA International | Member | Politique de santé de l'UE |
| 23 Sep 2025 | Amgen Inc ↗ | Member | APAs briefing session on Biotech Act |
| 12 Sep 2025 | Andros - Materne | Member | Politique commerciale et environementale de l'UE |
| 4 Sep 2025 | APCO Worldwide ↗ | Member | Biotech Alliance Secretariat - Presentation |
| 27 Aug 2025 | Samabriva | Member | Présentation de la technologie par cheveux racinaires |
| 27 Jun 2025 | International Diabetes Federation European Region | Shadow rapporteur | Politique de santé de l'UE |
| 26 Jun 2025 | Novartis International AG RPP Group | Member | Evènement - Thérapies par radioligands |
| 23 Jun 2025 | Alliance for Regenerative Medicine | Shadow rapporteur | Politique de santé de l'UE |
The full record is in the official EP declarations.
Roll-call voting record
Recorded votes only. Parliament held 5,568 roll-call votes while Olivier Chastel held the seat, 537 of them the final vote on a text. A member with no vote recorded may have been on parliamentary business, ill, on leave, or present without voting - the published record does not distinguish these and gives no reason. Votes taken by show of hands or by secret ballot are not recorded by name and are absent here.
How they voted on final texts
Share of the 537 final votes held while seated.
With and against the group
On the 483 final texts where more than half of Renew members casting a vote went one way, and Olivier Chastel also voted. Groups are not bound to vote together: a Member's mandate is personal and exercised freely, so neither figure is a measure of performance.
Final texts where Olivier Chastel differed from the Renew majority
| Date | Text | Their vote | Renew majority |
|---|---|---|---|
| 8 July 2026 | B10-0337/2026 – Motion for a resolution (as a whole) | For | Against |
| 8 July 2026 | A10-0181/2026 – Javi López, Borja Giménez Larraz – Proposal for a Council decision | Against | For |
| 29 April 2026 | A10-0098/2026 – Danuše Nerudová – Commission proposal | Abstained | For |
| 11 March 2026 | A10-0017/2026 – Tobias Cremer – Motion for a resolution (as a whole) | Against | For |
| 12 February 2026 | A10-0256/2025 – Johan Danielsson – Motion for a resolution (as a whole) | Against | For |
| 21 January 2026 | B10-0060/2026 – Motion for a resolution | For | Against |
| 21 January 2026 | A10-0253/2025 – David McAllister – Motion for a resolution (as a whole) | Abstained | For |
| 17 December 2025 | A10-0243/2025 – Christophe Gomart – Motion for a resolution (as a whole) | Abstained | For |
| 27 November 2025 | RC-B10-0545/2025 – Motion for a resolution (as a whole) | Abstained | For |
| 26 November 2025 | C10-0263/2025 – Commission proposal | For | Against |
3 further instances are not listed. All roll-call votes.
Unlinked but matchable
9 counterpart entrys in Olivier Chastel's declarations appear to match an EU Transparency Register entry without being linked in the declaration:
- “Alliance for Regenerative Medicine” - likely Alliance for Regenerative Medicine (1 counterpart entry)
- “Alpha-1 Europe Alliance asbl” - likely Alpha-1 Europe Alliance asbl (1 counterpart entry)
- “Ending discrimination against cancer survivors” - likely Ending Discrimination Against Cancer Survivors (1 counterpart entry)
Matching is automated and can be wrong - see how matching works. Linking the register entry is the fix, and it is the MEP office's to make.